As Senior Vice President, Global Marketing and Business Development for DIA, Ms. Svensson leads DIA’s worldwide strategic marketing and business development teams. Prior to joining DIA, Ms. Svensson led the strategic accounts team at Cardinal Health Specialty Solutions, delivering services and products that spanned product life-cycle, from regulatory and scientific consulting to commercialization, including analytics. She also conceptualized, crafted, and executed the new brand identity for Cardinal Health Specialty Solutions, for three strategic customer groups: providers, payers, and pharmaceutical clients. In her role at Cardinal Health, Ms. Svensson oversaw strategic marketing initiatives including new product/service development and enhancements, value-based pricing strategies, market segmentation, digital solutions, social media, voice of the customer research, new consultative services, and technology solutions.
Before joining Cardinal Health, Ms. Svensson held marketing, sales, and product management leadership roles at Pharmacia (now part of Pfizer), BMS, Acusphere, and AMAG Pharma. Ms. Svensson began her career with AstraZeneca, in Sweden, in sales and product management, and quickly expanded responsibility to include marketing across Europe, USA, and Latin America.
Ms. Svensson holds a BS in Business Administration and Economics from the University of Stockholm in Sweden.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China